Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorPeking Union Medical College Hospital
About this trial
An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.
Eligibility criteria
Qualifiers
Age <= 18 years old
Diagnosed with rheumatic and immunologic diseases (including diffuse connective tissue diseases, arthritis, vasculitis, inborn errors of immunity)
Diagnosed and Treated in China
Disqualifiers
Disagreement of involving in this study by the patient or his/her family.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Peking Union Medical College Hospital
Lead sponsor
Children's Hospital of Chongqing Medical University
Collaborator
Central South University
Collaborator
Beijing Children's Hospital
Collaborator
Shenzhen Children's Hospital
Collaborator
Children's Hospital of Nanjing Medical University
Collaborator
The University of Hong Kong
Collaborator
Zhejiang University
Collaborator
Peking University Third Hospital
Collaborator
Source ClinicalTrials.gov